These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 30569110)

  • 1. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
    Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDK1 Mediates
    Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
    Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers.
    Katase N; Nagano K; Fujita S
    J Oral Biosci; 2020 Mar; 62(1):9-15. PubMed ID: 32032750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.
    Chou MH; Chuang HC; Lin YT; Tsai MH; Kao YH; Lin IC; Huang TL; Fang FM; Chien CY
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
    Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
    BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
    Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
    Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway.
    Hu J; Li G; Liu Z; Ma H; Yuan W; Lu Z; Zhang D; Ling H; Zhang F; Liu Y; Liu C; Qiu Y
    Mol Carcinog; 2023 May; 62(5):628-640. PubMed ID: 36727616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
    Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
    Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
    Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
    Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing novel long non-coding RNA FKBP9P1 represses malignant progression and inhibits PI3K/AKT signaling of head and neck squamous cell carcinoma in vitro.
    Yang YF; Feng L; Shi Q; Ma HZ; He SZ; Hou LZ; Wang R; Fang JG
    Chin Med J (Engl); 2020 Sep; 133(17):2037-2043. PubMed ID: 32769488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma.
    Hu Y; Liu M; Xu S; Li S; Yang M; Su T; Yuan Z; Peng H
    Med Sci Monit; 2020 Nov; 26():e927368. PubMed ID: 33281184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Prostate Cancer DU-145 Cells Proliferation by
    Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G
    Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]   [Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
    Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
    Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.